Smart Grids Infrastructure Market, 2018-2030

Steffan98702 Jul, 2021Health

Around 300 product candidates are currently under various stages of development for a diverse range of indications. Eight gene therapies are commercially available; of these, Imlygic? (Amgen), Strimvelis? (GSK), Invossa? (TissueGene / Kolon Life Science / Mitsubishi Tanabe Pharma) and Luxturna? (Spark Therapeutics) were approved after 2015

Recent Profiles

Sunwin20 zacom

Sunwin20 Zacom

View Profile

Karanvir Singh

Karanvir Singh

View Profile

Oberheiden P.C.

Oberheiden P.c.

View Profile

Peter Mize

Peter Mize

View Profile

RIKVIP

Rikvip

View Profile

Marcio Alcantara

Marcio Alcantara

View Profile

MTV KDTH Đạt Phương

Mtv Kdth Đạt Phương

View Profile